Beyond T cells: B cells in immune checkpoint blockade.

Authors

Yumin Kim, In Kang, Heung Kyu Lee

Published in

Trends in immunology. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

Immune checkpoint blockade is usually framed as a T cell-directed therapy. Recent studies challenge this view by showing that B cells, plasma cells, and tumor-reactive antibodies are reshaped by programmed cell death protein-1 and cytotoxic T-lymphocyte-associated protein-4 blockade and can contribute to efficacy. Humoral immunity should therefore be integrated into models of checkpoint efficacy.

PMID:
42816192
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.